PhoenixBio Co.,Ltd., The Current Fiscal Year Ordinary Profit Revised Downward to a Loss

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Thu Nov 14, 2024 3:30 pm JST Earnings

6190 PhoenixBio Co.,Ltd. 【J-GAAP】

Earnings Report

PhoenixBio Co.,Ltd. <6190> [TSE-G] announced its financial results after the market closed on November 14th (15:30). The consolidated ordinary profit/loss for the cumulative second quarter of the fiscal year ending March 2025 (April to September) turned into a loss of 123 million yen (compared to a profit of 45 million yen in the same period last year), further increasing the deficit beyond the forecast of a loss of 5 million yen.

In addition, the full-year consolidated ordinary profit/loss has been revised downward from an expected profit of 214 million yen to a loss of 277 million yen (compared to a profit of 43 million yen in the previous period), turning to a loss outlook.

Based on the first-half performance announced by the company and the full-year plan, our calculation indicates that the consolidated ordinary loss for the October to March period (second half) is expected to expand to a loss of 154 million yen (compared to a loss of 2 million yen in the same period last year).

In the most recent three-month period, from July to September (2Q), the consolidated ordinary loss expanded to a loss of 148 million yen (compared to a loss of 2 million yen in the same period last year). The operating profit/loss margin drastically worsened from -2.7% in the same period last year to -30.4%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Sep, 2022	1,135	367	403	356	107.7	78.9	Nov 14, 2022	J-GAAP
Apr - Sep, 2023	881	-5	45	27	7.5	104.7	Nov 14, 2023	J-GAAP
Apr - Sep, 2024	788	-98	-123	-124	-30.9	ー	Nov 14, 2024	J-GAAP
YoY	-10.6%	-1,860.0%	－	－	－

First Half Results vs. Previous Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Apr - Sep, 2024 Guidance	972	-5	-5	-8	-2.0	0	May 15, 2024	J-GAAP
Apr - Sep, 2024 Results	788	-98	-123	-124	-30.9	0	Nov 14, 2024	J-GAAP
Revision Rate	-18.9%	-1,860.0%	-2,360.0%	-1,450.0%	-1,468.0%

Guidance Update

Full Year Update

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2025 Prev	2,121	214	214	201	49.6	0	May 15, 2024	J-GAAP
Mar, 2025 New	1,521	-253	-277	-281	-69.4	0	Nov 14, 2024	J-GAAP
Revision Rate	-28.3%	－	－	－	－

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2023	834	16	-2	-1	-0.3	0	May 15, 2024	J-GAAP
Oct - Mar, 2024 Guidance	733	-155	-154	-157	-38.8	0	Nov 14, 2024	J-GAAP
YoY	-12.1%	－	-7,600.0%	-15,600.0%	-14,255.6%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2023	2,124	508	511	493	145.2	0	May 15, 2023	J-GAAP
Mar, 2024	1,715	11	43	26	7.0	0	May 15, 2024	J-GAAP
Mar, 2025 Guidance	1,521	-253	-277	-281	-69.4	0	Nov 14, 2024	J-GAAP
YoY	-11.3%	－	－	－	－

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Jul - Sep, 2023	442	-12	-2	-15	-4.2	-2.7	Nov 14, 2023	J-GAAP
Oct - Dec, 2023	447	35	-13	-13	-3.6	7.8	Feb 14, 2024	J-GAAP
Jan - Mar, 2024	387	-19	11	12	3.2	-4.9	May 15, 2024	J-GAAP
Apr - Jun, 2024	449	5	25	23	5.8	1.1	Aug 13, 2024	J-GAAP
Jul - Sep, 2024	339	-103	-148	-147	-36.6	-30.4	Nov 14, 2024	J-GAAP
YoY	-23.3%	-758.3%	-7,300.0%	-880.0%	-776.1%